Ernexa Therapeutics Inc.

General ticker "ERNA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $139.3M (TTM average)

Ernexa Therapeutics Inc. does not follow the US Stock Market performance with the rate: -20.3%.

Estimated limits based on current volatility of 3.9%: low 1.22$, high 1.32$

Factors to consider:

  • Total employees count: 9 as of 2022
  • Current price 59.2% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [3.21$, 15.03$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.81$, 8.33$]

Financial Metrics affecting the ERNA estimates:

  • Positive: with PPE of -0.5 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -14.11 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Negative: Inventory ratio change, % of 73.64 > 0.84
  • Negative: Industry earnings per price (median), % of -16.34 <= 0
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term ERNA quotes

Long-term ERNA plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.07MM $0.58MM
Operating Expenses $33.22MM $21.20MM $16.26MM
Operating Income $-33.22MM $-21.14MM $-15.67MM
Non-Operating Income $8.68MM $-0.54MM $-28.84MM
Interest Expense $0.03MM $0.61MM $6.75MM
R&D Expense $10.39MM $5.92MM $4.60MM
Income(Loss) $-24.53MM $-21.67MM $-44.51MM
Taxes $0.04MM $-0.00MM $0.03MM
Profit(Loss)* $-24.58MM $-21.67MM $-44.54MM
Stockholders Equity $12.11MM $2.23MM $1.70MM
Assets $22.28MM $49.13MM $5.27MM
Operating Cash Flow $-20.98MM $-20.41MM $-15.84MM
Capital expenditure $0.30MM $0.02MM $0.37MM
Investing Cash Flow $-0.05MM $-0.02MM $-0.36MM
Financing Cash Flow $19.58MM $16.56MM $6.26MM
Earnings Per Share** $-8.06 $-4.08 $-1.57

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.